Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 08, 2019 10:40am

56 Views

Post# 30327181

RE:RE:RE:RE:RE:RE:RE:Longs don't forget your daily mantra...

vestor111 wrote:
They might be able to do GBM topically but GBM is so sinuously entangled in the brain with all the dendrites and high stem cell cancer issues, IV might be the way they go. Xrays certainly help this story as deep pentrating wavelengths in the IR spectrum.

The dosage concentrations are so low, it seems possible that multiple treatments would appear very possible as well to insure more complete irradication.

Passage through the BBB allows all of this.

This would be the ticket. IV and xray if/when studied and approved would be easy, safe?, repeatable, convenient, effective...etc.....

Bullboard Posts

How one company is disrupting PoC testing